Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors von Siu, Lillian L, Pili, Roberto, Duran, Ignacio, Messersmith, Wells A, Chen, Eric X, Sullivan, Rana, MacLean, Martha, King, Serina, Brown, Shirley, Reid, Gregory K, Li, Zuomei, Kalita, Ann M, Laille, Eric J, Besterman, Jeffrey M, Martell, Robert E, Carducci, Michael A

Volltext

Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015) von Rubio-San-Simón, Alba, van Eijkelenburg, Natasha K. A., Hoogendijk, Raoull, Hasle, Henrik, Niemeyer, Charlotte M., Dworzak, Michael N., Zecca, Marco, Lopez-Yurda, Marta, Janssen, Julie M., Huitema, Alwin D. R., van den Heuvel-Eibrink, Marry M., Laille, Eric J., van Tinteren, Harm, Zwaan, Christian M.

Volltext

Azacitidine von Rubio-San-Simón, Alba, van Eijkelenburg, Natasha K. A, Hoogendijk, Raoull, Hasle, Henrik, Niemeyer, Charlotte M, Dworzak, Michael N, Zecca, Marco, Lopez-Yurda, Marta, Janssen, Julie M, Huitema, Alwin D.R, van den Heuvel-Eibrink, Marry M, Laille, Eric J, van Tinteren, Harm, Zwaan, Christian M

Volltext

Plasma concentrations of praziquantel after oral administration of single and multiple doses in loggerhead sea turtles (Caretta caretta) von Jacobson, E.R, Harman, G.R, Maxwell, L.K, Laille, E.J

Volltext

A phase Ia study of CC-90003, a selective extracellular signal-regulated kinase (ERK) inhibitor, in patients with relapsed or refractory BRAF or RAS-mutant tumors von Mita, Monica M., LoRusso, Patricia, McArthur, Grant A., Kim, Edward S., Bray, Gordon L., Hock, Nanette H, Laille, Eric J., Aronchik, Ida, Filvaroff, Ellen, Wu, Xiaoling, Bendell, Johanna C.

Volltext

Phase I Study ofMGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors von SIU, Lillian L, PILI, Roberto, ZUOMEI LI, KALITA, Ann M, LAILLE, Eric J, BESTERMAN, Jeffrey M, MARTELL, Robert E, CARDUCCI, Michael A, DURAN, Ignacio, MESSERSMITH, Wells A, CHEN, Eric X, SULLIVAN, Rana, MACLEAN, Martha, KING, Serina, BROWN, Shirley, REID, Gregory K

Volltext

Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia von GARCIA-MANERO, Guillermo, GORE, Steven D, KANTARJIAN, Hagop, SKIKNE, Barry, COGLE, Christopher, WARD, Renee, TAO SHI, MACBETH, Kyle J, LAILLE, Eric, GIORDANO, Heidi, SAKOIAN, Sarah, JABBOUR, Elias

Volltext

Pharmacokinetics and Pharmacodynamics with Extended Dosing of CC-486 in Patients with Hematologic Malignancies von Laille, Eric, Shi, Tao, Garcia-Manero, Guillermo, Cogle, Christopher R, Gore, Steven D, Hetzer, Joel, Kumar, Keshava, Skikne, Barry, MacBeth, Kyle J

Volltext

Updated Results of the Phase I BALLI-01 Trial of UCART22 Process 2 (P2), an Anti-CD22 Allogeneic CAR-T Cell Product Manufactured By Cellectis Biologics, in Patients with Relapsed o... von Jain, Nitin, Chevallier, Patrice, Liu, Hongtao, Schiller, Gary J., Méar, Jean-Baptiste, DeAngelo, Daniel J., Curran, Kevin J, Grupp, Stephan, Baruchel, Andre, Balsat, Marie, LaCroce, Alexandra, Roudet, Caroline, Korngold, Ana B., Newhall, Kathryn J., Laille, Eric, Lee, Daniel J., Frattini, Mark G., Larson, Richard A., Boissel, Nicolas

Volltext

P1408: UPDATED RESULTS OF THE PHASE I BALLI‐01 TRIAL OF UCART22, AN ANTI‐CD22 ALLOGENEIC CAR‐T CELL PRODUCT, IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CD22+ B‐CELL ACUTE LYMPHO... von Boissel, Nicolas, Chevallier, Patrice, Curran, Kevin, Schiller, Gary, Liu, Hongtau, Larson, Richard, Deangelo, Daniel J., Mear, Jean‐Baptiste, Grupp, Stephan, Baruchel, André, Konopleva, Marina, Lacroce, Alexandra, Roudet, Caroline, Korngold, Ana, Newhall, Katie, Laille, Eric, Lee, Daniel, Frattini, Mark, Jain, Nitin

Volltext

Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors von Von Hoff, Daniel D, Rasco, Drew W, Heath, Elisabeth I, Munster, Pamela N, Schellens, Jan H M, Isambert, Nicolas, Le Tourneau, Christophe, O'Neil, Bert, Mathijssen, Ron H J, Lopez-Martin, Jose A, Edenfield, W Jeff, Martin, Miguel, LoRusso, Patricia M, Bray, Gordon L, DiMartino, Jorge, Nguyen, Aaron, Liu, Kejian, Laille, Eric, Bendell, Johanna C

Volltext

Quantitative determination of azacitidine triphosphate in peripheral blood mononuclear cells using liquid chromatography coupled with high-resolution mass spectrometry von Derissen, Ellen J.B., Hillebrand, Michel J.X., Rosing, Hilde, Otten, Hans M.M.B., Laille, Eric, Schellens, Jan H.M., Beijnen, Jos H.

Volltext

Extended Dosing of Oral Azacitidine (CC-486) for 14 and 21 Days Provides More Effective Methylation Reversal Than a 7-Day Schedule von Laille, Eric, Shi, Tao, Garcia-Manero, Guillermo, Cogle, Christopher R., Gore, Steven D., Kumar, Keshava J., Skikne, Barry S., MacBeth, Kyle J.

Volltext

Oral Azacitidine (AZA) Activity in Patients with Acute Myelogenous Leukemia (AML) von Gore, Steven D., Cogle, Christopher R., Skikne, Barry, Laille, Eric, Shi, Tao, MacBeth, Kyle J., Giordano, Heidi, Garcia-Manero, Guillermo

Volltext

Abstract B217: A Phase I study of CC-486 (oral azacitidine) to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of azacitidine administered alone and in combination wit... von Laille, Eric, Nguyen, Aaron N., Chen, Gengxi, Rasco, Drew, LoRusso, Patricia, Von Hoff, Daniel D., Bendell, Johanna, Munster, Pamela, Edenfield, William J., Ramanathan, Ramesh, Gonzalez, Michael B., Blackwood-Chirchir, Anne, DiMartino, Jorge

Volltext

Evaluation of Oral Azacitidine Using Extended Treatment Schedules: A Phase I Study von Garcia-Manero, Guillermo, Gore, Steven D., Cogle, Christopher R., Jabbour, Elias J., Ward, M. Renee, MacBeth, Kyle J., Laille, Eric, Giordano, Heidi, Kantarjian, Hagop M., Skikne, Barry S.

Volltext

A Comparative Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of Azacitidine Following Subcutaneous (SC) and Oral Administration in Subjects with Myelodysplastic Syndromes (MDS)... von MacBeth, Kyle J, Laille, Eric, Ning, Yuhong, Cogle, Christopher R., Skikne, Barry, Gore, Steven D., Garcia-Manero, Guillermo, Ward, M. Renee

Volltext

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Patients with Myelodysplastic Syndromes (MDS) or... von Garcia-Manero, Guillermo, Gore, Steven D., Skikne, Barry, Cogle, Christopher R., Ning, Yuhong, MacBeth, Kyle J, Laille, Eric, Ward, M. Renee

Volltext